000 01775 a2200481 4500
005 20250515135947.0
264 0 _c20081216
008 200812s 0 0 eng d
022 _a1521-0111
024 7 _a10.1124/mol.108.050104
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHasinoff, Brian B
245 0 0 _aMechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib.
_h[electronic resource]
260 _bMolecular pharmacology
_cDec 2008
300 _a1722-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAMP-Activated Protein Kinases
_xantagonists & inhibitors
650 0 4 _aAcetyl-CoA Carboxylase
_xmetabolism
650 0 4 _aAdenosine Triphosphate
_xbiosynthesis
650 0 4 _aAnimals
650 0 4 _aAnimals, Newborn
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aApoptosis
650 0 4 _aCells, Cultured
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aIndoles
_xtoxicity
650 0 4 _aL-Lactate Dehydrogenase
_xmetabolism
650 0 4 _aMetformin
_xpharmacology
650 0 4 _aMuscle Cells
_xdrug effects
650 0 4 _aOxidative Stress
650 0 4 _aPhenformin
_xpharmacology
650 0 4 _aPhosphorylation
650 0 4 _aPyrroles
_xtoxicity
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptor Protein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aRibosomal Protein S6 Kinases, 90-kDa
_xantagonists & inhibitors
650 0 4 _aSunitinib
700 1 _aPatel, Daywin
700 1 _aO'Hara, Kimberley A
773 0 _tMolecular pharmacology
_gvol. 74
_gno. 6
_gp. 1722-8
856 4 0 _uhttps://doi.org/10.1124/mol.108.050104
_zAvailable from publisher's website
999 _c18282429
_d18282429